Leap Therapeutics logo
VerifiedBiotechnology Research

Leap Therapeutics

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. For more information about Leap Therapeutics, visit or our public filings with the SEC that are available via EDGAR at or via

7-day free trial · no credit card

HeadquartersCambridge, United StatesEmployees25(11 to 50)Annual revenue$1M to <$10MWebsiteleaptx.comLinkedIn profileLinkedIn

Verified contacts

31

available on Kipplo

LinkedIn employees

25

11 to 50 range

Open roles

no listings

Distinct roles

25

indexed titles

Tech stack

5

tools in use

Monthly traffic

928

organic / mo

Sign up free to see all 31 verified contacts at Leap Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

31 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Leap Therapeutics

25 distinct titles indexed · top 10 shown.

  • 2associate director of analytical development and quality control
  • 1- &
  • 1associate director of analytical development and characterization
  • 1associate director, cmc downstream development and manufacturing
  • 1associate director, cmc project management
  • 1associate director, contracts & administration
  • 1board member
  • 1chief scientific officer
  • 1corporate controller
  • 1director
  • +15more titles

Sign up to unlock all 31 contacts at Leap Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 31 verified contacts at Leap Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Leap Therapeutics | Kipplo Discover